Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH).

Autor: Sacco S; Department of Applied Clinical Sciences and Biotechnology, University of L'Aquila, L'Aquila, Italy. simona.sacco@univaq.it., Merki-Feld GS; Clinic for Reproductive Endocrinology, Department of Gynecology, University Hospital, Zürich, Switzerland., Ægidius KL; Department of Neurology, Bispebjerg Hospital and University of Copenhagen, Copenhagen, Denmark., Bitzer J; Department of Obstetrics and Gynecology, University Hospital of Basel, Basel, Switzerland., Canonico M; Université Paris-Saclay, University Paris-Sud, UVSQ, CESP, Inserm UMRS1018, Paris, France., Gantenbein AR; Neurology & Neurorehabilitation, RehaClinic, Bad Zurzach, University of Zurich, Zürich, Switzerland., Kurth T; Institute of Public Health, Charité - Universitätsmedizin Berlin, Berlin, Germany., Lampl C; Headache Medical Center Seilerstaette Linz, Linz, Austria.; Department of Geriatric Medicine Ordensklinikum Linz, Linz, Austria., Lidegaard Ø; Department of Obstetrics & Gynaecology, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark., Anne MacGregor E; Centre for Neuroscience & Trauma, BICMS, Barts and the London School of Medicine and Dentistry, London, UK.; Barts Health NHS Trust, London, UK., MaassenVanDenBrink A; Erasmus Medical Center Rotterdam, Department of Internal Medicine, Division of Vascular Medicine and Pharmacology, Rotterdam, The Netherlands., Mitsikostas DD; Department of Neurology, University of Athens, Athens, Greece., Nappi RE; Research Centre for Reproductive Medicine, Gynecological Endocrinology and Menopause, IRCCS S. Matteo Foundation, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.; University Consortium for Adaptive Disorders and Head Pain (UCADH), University of Pavia, Pavia, Italy., Ntaios G; Department of Medicine, University of Thessaly, Larissa, Greece., Paemeleire K; Department of Neurology, Ghent University Hospital, Ghent, Belgium., Sandset PM; University Hospital Rikshospitalet, University of Oslo, Oslo, Norway., Terwindt GM; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands., Vetvik KG; Department of Neurology, Akershus University Hospital, Lørenskog, Norway., Martelletti P; Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy.
Jazyk: angličtina
Zdroj: The journal of headache and pain [J Headache Pain] 2018 Aug 31; Vol. 19 (1), pp. 76. Date of Electronic Publication: 2018 Aug 31.
DOI: 10.1186/s10194-018-0896-5
Abstrakt: We systematically reviewed data about the effect of exogenous estrogens and progestogens on the course of migraine during reproductive age. Thereafter a consensus procedure among international experts was undertaken to develop statements to support clinical decision making, in terms of possible effects on migraine course of exogenous estrogens and progestogens and on possible treatment of headache associated with the use or with the withdrawal of hormones. Overall, quality of current evidence is low. Recommendations are provided for all the compounds with available evidence including the conventional 21/7 combined hormonal contraception, the desogestrel only oral pill, combined oral contraceptives with shortened pill-free interval, combined oral contraceptives with estradiol supplementation during the pill-free interval, extended regimen of combined hormonal contraceptive with pill or patch, combined hormonal contraceptive vaginal ring, transdermal estradiol supplementation with gel, transdermal estradiol supplementation with patch, subcutaneous estrogen implant with cyclical oral progestogen. As the quality of available data is poor, further research is needed on this topic to improve the knowledge about the use of estrogens and progestogens in women with migraine. There is a need for better management of headaches related to the use of hormones or their withdrawal.
Databáze: MEDLINE